Navigation Links
Inhibition of oral biofilm and cell-cell communication using natural-products derivatives
Date:3/20/2014

Alexandria, Va., USA Today during the 43rd Annual Meeting & Exhibition of the American Association for Dental Research, held in conjunction with the 38th Annual Meeting of the Canadian Association for Dental Research, Steve Kasper, SUNY College of Nanoscale Science and Engineering, Albany, will present research titled "Inhibition of Oral Biofilm and Cell-cell Communication Using Natural-products Derivatives."

Many plant metabolites and structurally similar derivatives have been identified as inhibitors of bacterial biofilm formation and quorum sensing (QS). Previously, the researchers of this study demonstrated biofilm and QS inhibition using modified cysteines, similar to those produced by the tropical plant Petiveria alliacea. In this study the researchers expanded their compound library to examine structure-activity relationships for biofilm and QS inhibition.

Using a microplate-based screening approach, they observed the biofilm formation by three indigenous oral Gram-positive bacteria: Streptococcus mutans UA159, Streptococcus sanguis 10556, and Actinomyces oris MG1. Bacteria were grown in the presence of inhibitory compounds and analyzed using fluorescent staining for biomass and via confocal microscopy.

Compounds were also tested in a Vibrio harveyi QS reporter which responds to autoinducer-2 (AI-2) signaling (interspecies) but not acyl-homoserine lactone signaling (intraspecies). Reverse transcriptase real-time PCR and global RNA sequencing (RNAseq) were used to study modified genetic expression in S. mutans UA159 in the presence of select compounds from our library.

From their 46 compound library, six were capable of inhibiting biofilm formation in all three species tested at a concentration of 1mM. All six compounds are structurally similar to S-ribosyl homocysteine, the precursor for autoinducer-2 biosynthesis. These compounds also reduced bioluminescence in V. harveyi BB170, indicating inhibition of AI-2 based QS. Gene expression analysis showed distinct down-regulation of genes previously related to quorum sensing and/or biofilm formation in S. mutans.

The use of plant-inspired cysteine derivatives to inhibit bacterial virulence may serve as a novel tool to improve oral health. The researchers of this study propose that the compounds used in this study may inhibit biofilm formation by interrupting bacterial communication pathways, particularly in AI-2 biosynthetic reactions. Since their library is derived from eukaryotic (plant) origins, this study may provide initial evidence of interkingdom signaling, which has implications for studies of the human microbiome.


'/>"/>
Contact: Ingrid L. Thomas
ithomas@aadr.org
703-299-8084
International & American Associations for Dental Research
Source:Eurekalert

Related medicine news :

1. New STELARA data show inhibition of joint destruction in active psoriatic arthritis
2. Epoxide hydrolase inhibition and Thiazolidinediones: A therapy for cardiometabolic syndrome
3. Neurological Wellness Center's Novel Neuro-Inflammation Inhibition Procedure that Induces Rapid Recovery from Alzheimer's, Stroke and Brain Injury is Now Being Taught in a Newly Released Video
4. Novel test identifies patients most likely to benefit from ALK inhibition therapy
5. Treating drug resistant cancer through targeted inhibition of sphingosine kinase
6. Specific inhibition of autophagy may represent a new concept for treatment of kidney cancer
7. Scientific Biofilm Solutions Wants to Offer Tips on How to Properly Clean a Jetted Tub
8. OH YUK! Did You Know Your Jetted Hot Tub Houses All Sorts Of Harmful Bacteria and BioFilm?
9. GW researcher receives federal grant to study hedgehog regulation of cell-cell interaction
10. DocsInk.com Secures Nearly $1,000,000 in Series A Round to Power Healthcare Communication
11. How to Make 2014 the Year Your Agency Becomes More Efficient, Improves Communication and Goes Mobile with Online Services from Aladtec
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... (PRWEB) May 05, 2016 , ... Talent Tech Labs ... HireNurses, on the eve of National Nurses Week (May 6-12). Currently, HireNurses ... employers. With their enrollment into the Talent Tech Lab Virtual Incubation program, they will ...
(Date:5/5/2016)... ... May 05, 2016 , ... Chronic stress can have a silent, yet dangerous, ... the immune system and increase inflammation, both of which raise the risk of heart ... heart disease program at Harvard-affiliated Massachusetts General Hospital. Chronic stress also can lead to ...
(Date:5/5/2016)... Dallas, Texas (PRWEB) , ... May 05, 2016 ... ... and relationship-marketing firm, honored finalists and winners Tuesday evening, May 3, at the ... Dallas, Texas. , Scott Pettigrew, Vice President and Chief Security Officer of ...
(Date:5/5/2016)... , ... May 05, 2016 , ... If you don’t ... marks on your skin, you may want to consider a treatment that some have ... Advanced Dermatology P.C. , Microneedling, also known as skin needling, is a ...
(Date:5/5/2016)... ... May 05, 2016 , ... Pigment Laser Tattoo Removal Center is proud to ... new PiQo4™ laser, the first 4-wavelenth picosecond laser to receive FDA Clearance. This ... laser on the market. Jeremy Miller, Tattoo Artist and former reality show contestant ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... May 5, 2016 ... the  "Europe Systemic Lupus Erythematosus Market and ... their offering.       (Logo: ... research Europe Systemic Lupus Erythematosus Market and ... insights into Systemic Lupus Erythematosus pipeline products, ...
(Date:5/4/2016)... ZIONA, Israel , May 4, 2016 /PRNewswire/ ... announced today that BiondVax,s CEO, Dr. Ron Babecoff , ... New York City . On ... at Pioneers 2016, a conference presented by Joseph Gunner ... Hotel. The BiondVax presentation that Dr. Babecoff will ...
(Date:5/4/2016)... Jersey , May 4, 2016 ... successful completion of an alternative public offering (APO). This ... owned operating company, Valeritas, Inc. and a private placement ... stock at $5.00 per share. Under the ... May 3, 2016, Valeritas Holdings, Inc. will trade on ...
Breaking Medicine Technology: